Morgan Stanley Maintains Overweight on Equifax Inc. (EFX) Feb 04, 2026

Morgan Stanley maintained an Overweight on Equifax Inc. (EFX) on Feb 04, 2026, marking a steady bullish stance even as it axed its price target. The EFX analyst rating update shows the firm sees enduring EPS growth that the market may not yet value. Morgan Stanley published the call at 03:52 PM and described long-term earnings upside as underappreciated by current multiples. Investors should note the firm kept the positive rating but removed a public price target, a rare mix of conviction and caution

Key EFX analyst rating action on Feb 04, 2026

On Feb 04, 2026 Morgan Stanley maintained Overweight on Equifax Inc. and simultaneously axed its public price target. The firm cited enduring EPS growth that is not priced into shares. Read the Morgan Stanley note at TheFly for source context

Analyst rationale and EFX price target implications

Morgan Stanley says Equifax has durable EPS growth that the market underestimates, which explains the continued Overweight call. Axing the price target signals the firm prefers to highlight earnings trajectory rather than a single target level. For investors, the removal of a target increases reliance on fundamentals and upcoming earnings to guide valuation

Market reaction and EFX stock performance

At the time of the note the release recorded no immediate price move with reported price change 0.0% ($0.0). Equifax trades with a market cap of $22,301,804,447, a scale that limits single-note volatility. A maintained Overweight with no target often leads to muted short-term price action but can support a positive medium-term trend if EPS revisions follow

What the maintained Overweight means for investors

Maintained Overweight means Morgan Stanley expects EFX to outperform peers over its coverage horizon. Investors should treat the call as constructive but not definitive because the firm removed a price target. Use the rating as a signal to review growth assumptions, track quarterly EPS beats, and size positions against regulatory and data-risk factors

Historical analyst coverage and context for Equifax Inc.

Equifax has long been covered by major banks and independent research shops, with mixes of Buy, Hold, and Overweight stances over time. Morgan Stanley’s maintained Overweight aligns with other bullish pockets historically, but coverage has swung after regulatory or data events. Track multiple broker views to see whether Morgan Stanley’s conviction gains broader support

Meyka AI grade, outlook and next catalysts for EFX analyst rating

Meyka AI rates EFX with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Key near-term catalysts include quarterly EPS reports, consumer data trends, and regulatory updates. We use Meyka AI as an AI-powered market analysis platform to track changing analyst signals and to model scenario outcomes for EFX

Final Thoughts

Morgan Stanley’s Feb 04, 2026 note kept an Overweight on Equifax Inc. while axing its public price target, a combination that signals conviction in long-term earnings with short-term valuation uncertainty. The EFX analyst rating therefore reads as constructive but conditional. With a market cap of $22,301,804,447, Equifax sits in a position where steady EPS beats could lift sentiment, yet data risk and regulation remain tangible headwinds. Investors should treat the maintained Overweight as a prompt to reassess growth assumptions, monitor upcoming earnings, and compare views across analysts. Meyka AI rates EFX with a grade of B+, reflecting relative strength versus the S&P 500, solid sector placement, and positive analyst tilt. These grades are illustrative, not guaranteed, and do not replace personal financial advice. For traders, a clear next step is to watch EPS revisions and regulatory headlines that could validate or challenge Morgan Stanley’s stance

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.